Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

263 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Standardized pathological reporting for tumors].
Abbona GC, Papotti M, Montemurro F, Viberti L, Sapino A, Bussolati G. Abbona GC, et al. Among authors: montemurro f. Pathologica. 1997 Oct;89(5):546-65. Pathologica. 1997. PMID: 9489404 Italian. No abstract available.
Patients with advanced stage breast carcinoma immunoreactive to biotinylated Herceptin are most likely to benefit from trastuzumab-based therapy: an hypothesis-generating study.
Sapino A, Montemurro F, Marchiò C, Viale G, Kulka J, Donadio M, Bottini A, Botti G, dei Tos AP, Bersiga A, Di Palma S, Truini M, Sanna G, Aglietta M, Bussolati G. Sapino A, et al. Among authors: montemurro f. Ann Oncol. 2007 Dec;18(12):1963-8. doi: 10.1093/annonc/mdm417. Epub 2007 Sep 4. Ann Oncol. 2007. PMID: 17785760 Free article.
HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib.
Valabrega G, Capellero S, Cavalloni G, Zaccarello G, Petrelli A, Migliardi G, Milani A, Peraldo-Neia C, Gammaitoni L, Sapino A, Pecchioni C, Moggio A, Giordano S, Aglietta M, Montemurro F. Valabrega G, et al. Among authors: montemurro f. Breast Cancer Res Treat. 2011 Nov;130(1):29-40. doi: 10.1007/s10549-010-1281-5. Epub 2010 Dec 9. Breast Cancer Res Treat. 2011. PMID: 21153051
Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study.
Balmativola D, Marchiò C, Maule M, Chiusa L, Annaratone L, Maletta F, Montemurro F, Kulka J, Figueiredo P, Varga Z, Liepniece-Karele I, Cserni G, Arkoumani E, Amendoeira I, Callagy G, Reiner-Concin A, Cordoba A, Bianchi S, Decker T, Gläser D, Focke C, van Diest P, Grabau D, Lips E, Wesseling J, Arisio R, Medico E, Wells C, Sapino A. Balmativola D, et al. Among authors: montemurro f. Breast Cancer Res Treat. 2014 Dec;148(3):511-23. doi: 10.1007/s10549-014-3192-3. Epub 2014 Nov 14. Breast Cancer Res Treat. 2014. PMID: 25395316 Free PMC article.
Primary tumor location predicts the site of local relapse after nipple-areola complex (NAC) sparing mastectomy.
Cont NT, Maggiorotto F, Martincich L, Rivolin A, Kubatzki F, Sgandurra P, Marocco F, Magistris A, Gatti M, Balmativola D, Montemurro F, Sapino A, Ponzone R. Cont NT, et al. Among authors: montemurro f. Breast Cancer Res Treat. 2017 Aug;165(1):85-95. doi: 10.1007/s10549-017-4312-7. Epub 2017 May 28. Breast Cancer Res Treat. 2017. PMID: 28553683
263 results